Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,946 | -11,571 | -11,907 | -12,623 | -15,004 |
| Depreciation Amortization | 67 | 84 | 82 | 60 | 68 |
| Accounts receivable | 97 | 115 | -54 | 85 | -85 |
| Other Working Capital | -1,217 | 129 | -214 | -63 | 133 |
| Other Operating Activity | 973 | 1,269 | 1,532 | 2,175 | 2,531 |
| Operating Cash Flow | $-8,026 | $-9,974 | $-10,561 | $-10,366 | $-12,357 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -12 | -70 | -116 | -32 |
| Investing Cash Flow | $-6 | $-12 | $-70 | $-116 | $-32 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 506 |
| Common Stock Issued | 10,552 | 4,388 | 5,540 | 2,006 | 27,865 |
| Other Financing Activity | -1,252 | -662 | -418 | -59 | -160 |
| Financing Cash Flow | $9,300 | $3,726 | $5,122 | $1,947 | $28,211 |
| Beginning Cash Position | 1,103 | 7,363 | 12,872 | 21,407 | 5,585 |
| End Cash Position | 2,371 | 1,103 | 7,363 | 12,872 | 21,407 |
| Net Cash Flow | $1,268 | $-6,260 | $-5,509 | $-8,535 | $15,822 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,026 | -9,974 | -10,561 | -10,366 | -12,357 |
| Capital Expenditure | -6 | -12 | -70 | -116 | -32 |
| Free Cash Flow | -8,032 | -9,986 | -10,631 | -10,482 | -12,389 |